Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Cash (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Change in Cash data on record, last reported at $11.8 million in Q3 2025.

  • For Q3 2025, Change in Cash rose 168.2% year-over-year to $11.8 million; the TTM value through Sep 2025 reached $26.5 million, up 291.79%, while the annual FY2024 figure was -$24.5 million, 74.84% up from the prior year.
  • Change in Cash reached $11.8 million in Q3 2025 per FBIO's latest filing, up from -$17.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $56.5 million in Q1 2021 and bottomed at -$65.7 million in Q2 2023.
  • Average Change in Cash over 5 years is -$7.8 million, with a median of -$14.9 million recorded in 2021.
  • The widest YoY moves for Change in Cash: up 6279.89% in 2021, down 210.35% in 2021.
  • A 5-year view of Change in Cash shows it stood at $53.6 million in 2021, then plummeted by 155.26% to -$29.6 million in 2022, then soared by 129.1% to $8.6 million in 2023, then tumbled by 124.37% to -$2.1 million in 2024, then skyrocketed by 663.16% to $11.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were $11.8 million in Q3 2025, -$17.0 million in Q2 2025, and $33.7 million in Q1 2025.